Clinical Trials on Cardiorenal Syndrome Type 1
Total 6964 results
-
Instituto Nacional de Cardiologia Ignacio ChavezEchoNous Inc.RecruitingCardiorenal Syndrome Type 1Mexico
-
Chulalongkorn UniversityNot yet recruitingEmpagliflozin in Cardiorenal Syndrome Type 1Thailand
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiorenal Syndrome (CRS)United States
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Enrolling by invitationHeart Failure | Cardiorenal Disease | Renal DisfunctionUnited States
-
University of Texas Southwestern Medical CenterRecruitingGlucose Transporter Type 1 Deficiency Syndrome | GLUT1 Deficiency Syndrome | Glucose Transporter type1 (GLUT-1) Deficiency | GLUT-1 Deficiency SyndromeUnited States
-
University of Texas Southwestern Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS)Active, not recruitingGlucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport Defect | GLUT1DS1United States
-
Juan PascualNational Institute of Neurological Disorders and Stroke (NINDS)CompletedGlucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport Defect | GLUT1DS1United States
-
Hospital Civil de GuadalajaraCompleted
-
Horng ChenFlowMedica, Inc.TerminatedCardiorenal SyndromeUnited States
-
Maimonides Medical CenterWithdrawn
-
University of Texas Southwestern Medical CenterRecruitingGlucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1 | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport DefectUnited States
-
Ankara UniversityCompletedCardiorenal SyndromeTurkey
-
University of British ColumbiaUltragenyx Pharmaceutical IncUnknownGlucose Transporter Type 1 Deficiency SyndromeCanada
-
Juan PascualNo longer availableGlucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency SyndromeUnited States
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompletedCardiorenal SyndromeSweden
-
Virginia Commonwealth UniversityTerminatedCongestive Heart Failure | Cardiorenal SyndromeUnited States
-
Juan PascualCompletedGlucose Transporter Type 1 Deficiency Syndrome | GLUT1 Deficiency SyndromeUnited States
-
Juan PascualWithdrawnGlucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency SyndromeUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Nuwellis, Inc.Completed
-
Juan PascualActive, not recruitingGlucose Transporter Type 1 Deficiency Syndrome | GLUT1DS1United States
-
I.M. Sechenov First Moscow State Medical UniversityCompletedCongestive Heart FailureRussian Federation
-
Niguarda HospitalAssociazione Nazionale Medici Cardiologi OspedalieriTerminatedAcute Decompensated Heart FailureItaly
-
Nantes University HospitalUnknownLong QT Syndrome Type 1 or 2France
-
Ultragenyx Pharmaceutical IncCompletedGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)United States, Spain, Australia, France, Israel, Italy, United Kingdom
-
Ultragenyx Pharmaceutical IncAvailableGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
-
Pro-Cardiaco HospitalUniversidade Federal Fluminense; Hospital Universitário Antonio Pedro; Diagnósticos...Terminated
-
Ural State Medical UniversityUral Institute of Cardiology; De Haar Research FoundationCompletedCardiorenal Syndrome | Chronic Allograft NephropathyNetherlands, Russian Federation
-
Massachusetts General HospitalCompletedAcute Decompensated Heart Failure | Cardiorenal SyndromeUnited States, Italy
-
Merck Sharp & Dohme LLCWithdrawnHIV-1 | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1 | Human Immunodeficiency Virus 1
-
University of California, San FranciscoCompletedChronic Kidney Disease | Cardiorenal SyndromeUnited States
-
Mayo ClinicElgene ChemicalCompletedComplex Regional Pain Syndrome, Type 1United States
-
UMC UtrechtDutch Heart FoundationCompletedRenal Insufficiency, Chronic | Heart Failure, CongestiveNetherlands
-
Adrian LacyUltragenyx Pharmaceutical IncCompletedGlucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)United States
-
Institut de Recherches Cliniques de MontrealCompletedMetabolic Syndrome | Type 1 DiabetesCanada
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
Universidad Juárez Autónoma de TabascoCompletedMetabolic Syndrome | Insulin Resistance | Type 1 DiabetesMexico
-
University of GiessenWithdrawnComplex Regional Pain Syndrome Type 1Germany
-
Centre Hospitalier Universitaire, AmiensRecruiting
-
Sequana Medical N.V.Yale UniversityCompletedHeart Failure | Congestive Heart Failure | Sodium Excess | Sodium Disorder | Cardiorenal Syndrome | Volume OverloadBelgium, Georgia
-
Ultragenyx Pharmaceutical IncTerminatedGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)United States, Spain, France, Germany, Italy, United Kingdom
-
Yale UniversityAmerican Heart AssociationRecruitingCardiorenal SyndromeUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Legius SyndromeUnited States
-
3ive LabsCompletedCardiorenal SyndromeUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompleted
-
Hospices Civils de LyonCompletedNeuropathic Pain | Complex Regional Pain Syndrome Type 1France
-
Baylor Research InstituteCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease | Left Ventricular Diastolic DysfunctionUnited States
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
Medical University InnsbruckUnknown
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States